Key result
Therapy with statins or RAAS blockers showed no protective effect against atrial fibrillation recurrence after pulmonary vein isolation in postmenopausal women.
Why the study?
Do statins or RAAS antagonists prevent atrial fibrillation recurrence after pulmonary vein isolation in postmenopausal women?
Do statins or RAAS antagonists prevent atrial fibrillation recurrence after pulmonary vein isolation in postmenopausal women?
No takes yet. Share an insight, caveat, or question.
Statins and RAAS blockers do not appear to prevent atrial fibrillation recurrence after pulmonary vein isolation in postmenopausal women, likely because significant atrial remodeling has already occurred.
Folkeringa et al. (2010) conducted an editorial in Atrial fibrillation (n=372). Statins or RAAS blockers vs. Not using statins or RAAS blockers was evaluated on Atrial fibrillation recurrences after pulmonary vein isolation. Therapy with statins or RAAS blockers showed no protective effect against atrial fibrillation recurrence after pulmonary vein isolation in postmenopausal women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: